News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Alexion
NEWS
JOBS
IN THE PRESS
NEWS
Pharm Country
UK Watchdog Backs Alexion Pharmaceuticals Inc.'s “Very Expensive” Drug Soliris
September 4, 2014
·
2 min read
Pharm Country
How a $440,000 Drug is Making Alexion Pharmaceuticals Inc. a Biotech Powerhouse
September 6, 2012
·
1 min read
The Day In Review: AtheroGenics Tumbles On Drug Test Failure
March 19, 2007
·
1 min read
Biotech Beach
The Day In Review: Diabetes News Rules
June 13, 2006
·
1 min read
Pharm Country
Drug Could Cut Heart Surgery Risks
October 19, 2005
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Drug Development
Alexion Submits Application for Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the European Union (EU)
June 28, 2018
·
14 min read
FDA
Alexion Submits Application for Priority Review and Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the U.S.
June 19, 2018
·
13 min read
Drug Development
Alexion Announces Selection of Positive Phase 3 Clinical Data for ALXN1210 in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) for Late-Breaking Oral Presentation at Annual Conference of the European Hematology Association (EHA)
June 14, 2018
·
11 min read
Business
BridgeBio Pharma Enters into Agreement to Acquire Late Stage Therapy for Ultra-Rare Disorder from Alexion; Launches Origin Biosciences to Develop and Commercialize Therapy
June 11, 2018
·
3 min read
Business
Alexion and Complement Pharma Announce Partnership to Co-Develop Pre-Clinical Complement Inhibitor for Neurodegenerative Disorders
June 11, 2018
·
6 min read
Pharm Country
Alexion to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
June 5, 2018
·
1 min read
Drug Development
Halozyme Identifies Plasma Biomarkers As Potential Predictors Of Survival In Pancreatic Cancer
June 1, 2018
·
7 min read
Business
Gemini Therapeutics Strengthens Senior Leadership Team with Key Appointments and Promotion
May 30, 2018
·
3 min read
Deals
Alexion Offer for Wilson Therapeutics Accepted
May 25, 2018
·
6 min read
Business
Alexion Reports First Quarter 2018 Results and Positive Topline Data from ALXN1210 Phase 3 PNH Switch Study
April 26, 2018
·
24 min read
